Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.

作者: Christopher J. French , A.K.M. Tarikuz Zaman , Burton E. Sobel

DOI: 10.1097/MCA.0B013E32832C8CBB

关键词: Myocardial infarctionMedicineCreatine kinaseLigationAnterior Descending Coronary ArteryCardiologyErythropoietinCoronary occlusionInternal medicineIschemic myocardiumSaline

摘要: OBJECTIVES Erythropoietin (EPO) has been thought to be capable of potentiating protection jeopardized myocardium by reperfusion in evolving myocardial infarction. However, diversity study design and measurements infarct size studies evaluating EPO led inconsistent results. We sought characterize the effect on after ischemia with use assessment left-ventricular (LV) creatine kinase (CK) depletion echocardiography. METHODS Acute coronary occlusion was induced 10-week-old C57BL6 mice left anterior descending artery ligation for 3 h followed 72 reperfusion. (10,000 U/kg) or an equivalent amount saline vehicle alone injected intraperitoneally before immediately onset Assays residual LV CK activity calculation were performed homogenates harvested measurement size, echocardiography harvest tissue function. RESULTS Mice administered had similar (37.1+/-4.1%) echo scores (22.9+/-0.4) compared those corresponding control (35.29+/-1.9 21.3+/-1.1%, respectively). (39.1+/-4.8%) (19.5+/-1.0) (40.3+/-4.9 21.5+/-1.9%, CONCLUSION does not protect ischemic such that can yield additional salvage.

参考文章(43)
Erik Lipšic, Regien G. Schoemaker, Peter van der Meer, Adriaan A. Voors, Dirk J. van Veldhuisen, Wiek H. van Gilst, Protective Effects of Erythropoietin in Cardiac Ischemia Journal of the American College of Cardiology. ,vol. 48, pp. 2161- 2167 ,(2006) , 10.1016/J.JACC.2006.08.031
S B Rosalki, An improved procedure for serum creatine phosphokinase determination. Journal of Laboratory and Clinical Medicine. ,vol. 69, pp. 696- 705 ,(1967) , 10.5555/URI:PII:0022214367901795
Paul R. Hanlon, Ping Fu, Gary L. Wright, Charles Steenbergen, Murat O. Arcasoy, Elizabeth Murphy, Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling The FASEB Journal. ,vol. 19, pp. 1323- 1325 ,(2005) , 10.1096/FJ.04-3545FJE
Christopher J. French, Jeffrey L. Spees, A. K. M. Tarikuz Zaman, Douglas J. Taatjes, Burton E. Sobel, The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion. The FASEB Journal. ,vol. 23, pp. 1177- 1185 ,(2009) , 10.1096/FJ.08-116509
JAMES W. COVELL, JOHN ROSS, EUGENE BRAUNWALD, PETER R. MAROKO, JOHN K. KJEKSHUS, BURTON E. SOBEL, TAN WATANABE, Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions Circulation. ,vol. 43, pp. 67- 82 ,(1971) , 10.1161/01.CIR.43.1.67
Anthony John Bullard, Derek Miles Yellon, Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro. Cardiovascular Drugs and Therapy. ,vol. 19, pp. 333- 336 ,(2005) , 10.1007/S10557-005-4595-5
Sharon L Hale, Casilde Sesti, Robert A Kloner, Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat. Journal of Cardiovascular Pharmacology. ,vol. 46, pp. 211- 215 ,(2005) , 10.1097/01.FJC.0000171751.05446.C5
R Roberts, P D Henry, B E Sobel, An improved basis for enzymatic estimation of infarct size. Circulation. ,vol. 52, pp. 743- 754 ,(1975) , 10.1161/01.CIR.52.5.743